Arrhythmia issues in patients with renal disease

Seminars in Nephrology

Volumn 21, Issue 1, 2001, Pages 57-65

  Kocheril, Abraham G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; IBUTILIDE; LIDOCAINE; METOPROLOL; MEXILETINE; MORACIZINE; NIFEDIPINE; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CATHETER ABLATION; DEFIBRILLATION; DISEASE PREDISPOSITION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; KIDNEY DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL;

EID: 0035138479     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2001.18379     Document Type: Article

References (57)

1. Cardiovascular disease and the kidney: An epidemiologic overview
2. Cardiovascular disease in the renal patient: Prevention and treatment update
3. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - Pharmacological approaches
4. Cardiac disease in chronic uremia: Management
5. Sudden cardiac death: I. A decade's experience with out-of-hospital resuscitation; and II. Outcome of resuscitation, management, and future directions
6. Multicenter post infarction research group. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction
7. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
8. A randomized study of the prevention of sudden death in patients with coronary artery disease
9. Prediction of arrhythmia risk based on signal-averaged ECG in postinfarction patients
10. Baroreflex sensitivity and heart rate variability in the prognostic evaluation of post-myocardial infarction patients: The ATRAMI study
11. Increased regional and transmyocardial dispersion of ventricular repolarization in end-stage renal disease
12. T-wave alternans predicts arrhythmia vulnerability in patients undergoing electrophysiology study
13. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial
14. Disposition of intravenous amiodarone in subjects with normal and impaired renal function
15. Sotalol-induced torsades de pointes in patients with renal failure
16. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
17. Secondary prevention of sudden death: The Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study
18. Epidemiologic features of chronic atrial fibrillation. The Framingham Study
19. Electrocardiographic abnormalities in patients receiving hemodialysis
20. Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation
21. The effect of low dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation
22. Stroke prevention in atrial fibrillation study: Final results
23. Canadian atrial fibrillation anticoagulation (CAFA) study
24. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
25. Verapamil deleterious effects in chronic renal failure
26. Interaction between digoxin and calcium antagonists and antiarrhythmic drugs
27. The digoxinpropafenone interaction: Characterization of a mechanism using renal tubular cell monolayers
28. Toxic digoxin-drug interactions: The major role of renal P-glycoprotein
29. Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease
30. Recurrent torsades de pointes after sotalol therapy for symptomatic paroxysmal atrial fibrillation in a patient with end-stage renal disease
31. Propafenone in the conversion of atrial fibrillation in patients suffering from chronic renal failure
32. Propafenone disposition during continuous venovenous hemofiltration
33. Pharmacokinetics and optimum dose of disopyramide in patients with chronic renal failure
34. Acute renal failure after ibutilide
35. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation
36. Results of maze surgery for lone paroxysmal atrial fibrillation
37. Results of linear lesions created by a multielectrode ablation catheter in patients with recurrent atrial fibrillation
38. Holter monitoring in chronic renal failure before and during dialysis
39. Patterns of catheter ablation practice in the United States: Results of the 1992 NASPE survey
40. Radiofrequency ablation of an accessory pathway in a patient with corrected Ebstein's anomaly
41. Guidelines for implantation of cardiac pacemakers and antiarrhythmic devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation)
42. Prospective randomized trial of atrial versus ventricular pacing in sick sinus syndrome
43. Intraatrial conduction delay associated with an epicardial implantable cardioverter-defibrillator
44. Cardiac resynchronization for heart failure: Do patients with prior indications for pacing benefit?
45. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay
46. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation
47. Cardiac arrhythmias on hemodialysis in chronic renal failure patients
48. Cardiac arrhythmia in chronic renal failure: Holter monitoring during hemodialysis and intermittent peritoneal dialysis
49. Cardiac arrhythmias in end-stage renal disease
50. Cardiac arrhythmias in chronic renal failure? Holter monitoring during dialysis and everyday activity at home
51. Cardiac arrhythmias in patients on maintenance hemodialysis
52. Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors
53. Blood pressure and the risk of complex arrhythmia in renal insufficiency, hemodialysis, and renal transplant patients
54. Left ventricular hypertrophy as a risk factor for arrhythmias in hemodialysis patients
55. Heart rate variability and cardiac arrhythmias in patients with chronic renal failure
56. Long QTc and torsades de pointes in human immunodeficiency virus disease
57. Factors related to the QT prolongation in chronic renal failure